It has been reported that the differentiation status of cancer is associated with its response to targeted therapies, but the underlying molecular mechanism remains obscure.39 Our data showed that enforced HNF3γ expression sensitized HCC cells to sorafenib-induced growth inhibition and cell apoptosis. Here, FOXA3 is linked to cancer.